These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33656296)

  • 21. Tales from the future-nuclear cardio-oncology, from prediction to diagnosis and monitoring.
    Mikail N; Chequer R; Imperiale A; Meisel A; Bengs S; Portmann A; Gimelli A; Buechel RR; Gebhard C; Rossi A
    Eur Heart J Cardiovasc Imaging; 2023 Aug; 24(9):1129-1145. PubMed ID: 37467476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertension management in cardio-oncology.
    Essa H; Dobson R; Wright D; Lip GYH
    J Hum Hypertens; 2020 Oct; 34(10):673-681. PubMed ID: 32747676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET Tracers for Imaging Cardiac Function in Cardio-oncology.
    Kelly JM; Babich JW
    Curr Cardiol Rep; 2022 Mar; 24(3):247-260. PubMed ID: 35028820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brazilian cardio-oncology: the 10-year experience of the Instituto do Cancer do Estado de Sao Paulo.
    Costa IBSDS; Bittar CS; Fonseca SMR; E Silva CMPD; Dos Santos Rehder MHH; Rizk SI; Cruz CBBV; Figueiredo CS; de A Andrade FT; Barberino LA; de S Costa FA; Machado LP; González TB; Almeida MPC; Fukushima JT; Kalil Filho R; Hajjar LA
    BMC Cardiovasc Disord; 2020 Apr; 20(1):206. PubMed ID: 32345217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiotoxicity of anticancer therapies. Towards the implementation of cardio-oncology units].
    Hameau R; Gabrielli L; Garrido M; Guzmán AM; Retamal I; Vacarezza MJ; Greig D; Ocqueteau M; Sánchez C; Pizarro M; Corvalán A; Lavandero S; Castro PF; Martínez G
    Rev Med Chil; 2018 Jan; 146(1):68-77. PubMed ID: 29806680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying cancer patients at risk for cardiotoxicity.
    Salvatici M; Sandri MT
    Future Oncol; 2015; 11(14):2077-91. PubMed ID: 26198838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictability of cardiotoxicity: Experience of a Belgian cardio-oncology clinic.
    Jacobs JEJ; Guler I; Duchenne J; Janssens S; Van Aelst LNL
    Int J Cardiol; 2022 Sep; 363():119-122. PubMed ID: 35777489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism.
    Zhao Y; Jia H; Hua X; An T; Song J
    Curr Cardiol Rep; 2023 Aug; 25(8):863-878. PubMed ID: 37493874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Biomarkers in Cardio-Oncology.
    Ananthan K; Lyon AR
    J Cardiovasc Transl Res; 2020 Jun; 13(3):431-450. PubMed ID: 32642841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardio-Oncology: Progress in Diagnosis and Treatment of Cardiac Dysfunction.
    Tromp J; Steggink LC; Van Veldhuisen DJ; Gietema JA; van der Meer P
    Clin Pharmacol Ther; 2017 Apr; 101(4):481-490. PubMed ID: 28073142
    [No Abstract]   [Full Text] [Related]  

  • 31. Shining Damaged Hearts: Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear Cardiology.
    Kersting D; Settelmeier S; Mavroeidi IA; Herrmann K; Seifert R; Rischpler C
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncologic therapies associated with cardiac toxicities: how to minimize the risks.
    Cardinale D; Stivala F; Cipolla CM
    Expert Rev Anticancer Ther; 2019 May; 19(5):359-374. PubMed ID: 30916598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disparities in cardio-oncology: Implication of angiogenesis, inflammation, and chemotherapy.
    Vera CD; López AR; Ewaneewane AS; Lewis K; Parmisano S; Mondejar-Parreño G; Upadhyaya C; Mullen M
    Life Sci; 2023 Nov; 332():122106. PubMed ID: 37730108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease.
    Totzeck M; Schuler M; Stuschke M; Heusch G; Rassaf T
    Int J Cardiol; 2019 Apr; 280():163-175. PubMed ID: 30661849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
    Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
    CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Cardio-Oncology in the Interprofessional Care of Adult Patients Receiving Cancer Therapy.
    Pituskin E; Paterson I; Cox-Kennett N; Rothe D; Perri M; Becher H
    Semin Oncol Nurs; 2017 Nov; 33(4):384-392. PubMed ID: 28941563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardio-oncology: the role of advanced echocardiography in cancer patients.
    Venneri L; Zoppellaro G; Khattar RS
    Expert Rev Cardiovasc Ther; 2018 Apr; 16(4):249-258. PubMed ID: 29457984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart failure and chemotherapeutic agents.
    Piper S; McDonagh T
    Future Cardiol; 2015 Jul; 11(4):453-70. PubMed ID: 26234158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular toxicity of biologic agents for cancer therapy.
    Bhave M; Akhter N; Rosen ST
    Oncology (Williston Park); 2014 Jun; 28(6):482-90. PubMed ID: 25134321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Update on the Role of Cardiac Magnetic Resonance Imaging in Cancer Patients.
    Pons-Riverola A; Ghosh AK
    Curr Cardiol Rep; 2022 Dec; 24(12):2139-2147. PubMed ID: 36342641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.